Elisabeth M. Battinelli, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Platelets | 24 | 2023 | 2508 | 4.230 |
Why?
|
| Megakaryocytes | 9 | 2022 | 545 | 2.890 |
Why?
|
| Platelet Count | 1 | 2024 | 781 | 0.780 |
Why?
|
| Blood Platelet Disorders | 1 | 2021 | 58 | 0.770 |
Why?
|
| Neovascularization, Physiologic | 4 | 2023 | 1351 | 0.760 |
Why?
|
| Secretory Vesicles | 2 | 2011 | 124 | 0.700 |
Why?
|
| Platelet Aggregation Inhibitors | 5 | 2022 | 3068 | 0.660 |
Why?
|
| Blood Coagulation Disorders | 3 | 2021 | 337 | 0.660 |
Why?
|
| Lymphatic Vessels | 1 | 2023 | 353 | 0.650 |
Why?
|
| RNA, Neoplasm | 1 | 2021 | 769 | 0.640 |
Why?
|
| Platelet Activation | 3 | 2021 | 673 | 0.620 |
Why?
|
| Neovascularization, Pathologic | 5 | 2023 | 2635 | 0.610 |
Why?
|
| Anticoagulants | 6 | 2023 | 4599 | 0.610 |
Why?
|
| Cytoplasmic Granules | 1 | 2019 | 610 | 0.580 |
Why?
|
| Chemokine CCL5 | 1 | 2015 | 209 | 0.510 |
Why?
|
| Neoplasms | 6 | 2023 | 21683 | 0.510 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2014 | 131 | 0.430 |
Why?
|
| Thrombopoiesis | 2 | 2019 | 153 | 0.430 |
Why?
|
| ADAM Proteins | 1 | 2014 | 243 | 0.420 |
Why?
|
| Aspirin | 3 | 2022 | 3282 | 0.420 |
Why?
|
| Tamoxifen | 1 | 2017 | 981 | 0.420 |
Why?
|
| Angiogenesis Modulating Agents | 1 | 2011 | 8 | 0.410 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2014 | 255 | 0.400 |
Why?
|
| Lupus Coagulation Inhibitor | 2 | 2024 | 31 | 0.400 |
Why?
|
| beta-Alanine | 1 | 2011 | 74 | 0.390 |
Why?
|
| Antidotes | 1 | 2011 | 138 | 0.380 |
Why?
|
| Thrombosis | 4 | 2020 | 2968 | 0.360 |
Why?
|
| Blood Coagulation Factors | 1 | 2011 | 355 | 0.340 |
Why?
|
| Blood Coagulation | 2 | 2013 | 1127 | 0.340 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 2011 | 183 | 0.340 |
Why?
|
| Venous Thromboembolism | 2 | 2012 | 1671 | 0.330 |
Why?
|
| Neoplasm Proteins | 1 | 2021 | 3703 | 0.330 |
Why?
|
| Morpholines | 1 | 2011 | 571 | 0.320 |
Why?
|
| Catechol O-Methyltransferase | 2 | 2019 | 245 | 0.300 |
Why?
|
| Erythrocytes | 1 | 2017 | 2455 | 0.300 |
Why?
|
| Pre-Eclampsia | 2 | 2014 | 1200 | 0.300 |
Why?
|
| Thiophenes | 1 | 2011 | 588 | 0.290 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2017 | 2038 | 0.290 |
Why?
|
| Benzimidazoles | 1 | 2011 | 850 | 0.280 |
Why?
|
| Cell Movement | 1 | 2017 | 5217 | 0.250 |
Why?
|
| Neoplasm Metastasis | 3 | 2021 | 4851 | 0.240 |
Why?
|
| Nitric Oxide | 3 | 2001 | 2132 | 0.230 |
Why?
|
| Platelet Factor 4 | 1 | 2023 | 129 | 0.230 |
Why?
|
| Antiphospholipid Syndrome | 2 | 2018 | 173 | 0.230 |
Why?
|
| Protein Transport | 1 | 2009 | 1988 | 0.230 |
Why?
|
| Cathepsin G | 1 | 2022 | 32 | 0.220 |
Why?
|
| Prothrombin Time | 2 | 2024 | 119 | 0.220 |
Why?
|
| Breast Neoplasms | 4 | 2019 | 20822 | 0.210 |
Why?
|
| Microtubules | 2 | 2008 | 1090 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3133 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3240 | 0.210 |
Why?
|
| Partial Thromboplastin Time | 2 | 2024 | 206 | 0.210 |
Why?
|
| Signal Transduction | 4 | 2021 | 23403 | 0.210 |
Why?
|
| Humans | 44 | 2024 | 744343 | 0.200 |
Why?
|
| Platelet Aggregation | 3 | 2020 | 798 | 0.190 |
Why?
|
| Hemorrhage | 2 | 2023 | 3461 | 0.190 |
Why?
|
| Primary Health Care | 1 | 2016 | 4558 | 0.180 |
Why?
|
| Pandemics | 1 | 2020 | 8388 | 0.180 |
Why?
|
| Biological Transport | 2 | 2019 | 2118 | 0.180 |
Why?
|
| Epidermal Growth Factor | 1 | 2022 | 708 | 0.180 |
Why?
|
| Eye Proteins | 4 | 1996 | 646 | 0.170 |
Why?
|
| Pyridones | 1 | 2023 | 712 | 0.170 |
Why?
|
| alpha-Tocopherol | 1 | 2019 | 127 | 0.170 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2017 | 3508 | 0.160 |
Why?
|
| Autopsy | 1 | 2022 | 1020 | 0.160 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 2 | 2020 | 426 | 0.160 |
Why?
|
| Lymphopenia | 1 | 2021 | 285 | 0.160 |
Why?
|
| Pulmonary Circulation | 1 | 2021 | 739 | 0.160 |
Why?
|
| Cell Membrane | 1 | 2007 | 3748 | 0.150 |
Why?
|
| Heparin | 2 | 2023 | 1637 | 0.150 |
Why?
|
| Coculture Techniques | 2 | 2017 | 1341 | 0.140 |
Why?
|
| Venous Thrombosis | 1 | 2005 | 1239 | 0.140 |
Why?
|
| Hematologic Tests | 1 | 2016 | 240 | 0.130 |
Why?
|
| Cyclohexanes | 1 | 2015 | 152 | 0.130 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2019 | 2505 | 0.130 |
Why?
|
| Mice | 12 | 2022 | 81183 | 0.130 |
Why?
|
| Animals | 14 | 2022 | 168757 | 0.120 |
Why?
|
| Cell Adhesion | 1 | 2021 | 3144 | 0.120 |
Why?
|
| Blindness | 2 | 1996 | 617 | 0.120 |
Why?
|
| Interferon-gamma | 1 | 2022 | 3206 | 0.120 |
Why?
|
| Receptors, CCR5 | 1 | 2015 | 497 | 0.110 |
Why?
|
| Angiogenic Proteins | 1 | 2013 | 104 | 0.110 |
Why?
|
| Receptor, PAR-1 | 1 | 2013 | 113 | 0.110 |
Why?
|
| Antibodies, Neutralizing | 1 | 2022 | 1978 | 0.110 |
Why?
|
| Pregnancy | 4 | 2024 | 29144 | 0.110 |
Why?
|
| Leukocytes | 1 | 2021 | 2043 | 0.110 |
Why?
|
| Deafness | 2 | 1996 | 458 | 0.110 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 972 | 0.100 |
Why?
|
| Hematopoiesis | 1 | 2001 | 2072 | 0.100 |
Why?
|
| Antioxidants | 1 | 2000 | 1663 | 0.100 |
Why?
|
| C-Reactive Protein | 1 | 2024 | 3778 | 0.100 |
Why?
|
| S-Nitrosoglutathione | 2 | 2001 | 23 | 0.100 |
Why?
|
| Thromboxane A2 | 1 | 2011 | 92 | 0.100 |
Why?
|
| Acute Kidney Injury | 1 | 2023 | 1972 | 0.100 |
Why?
|
| Endostatins | 1 | 2011 | 174 | 0.100 |
Why?
|
| Bone Marrow Cells | 3 | 2012 | 2513 | 0.090 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 2916 | 0.090 |
Why?
|
| Factor V | 1 | 2011 | 178 | 0.090 |
Why?
|
| Adenosine Diphosphate | 1 | 2011 | 425 | 0.090 |
Why?
|
| DNA Damage | 1 | 2000 | 2432 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 2503 | 0.090 |
Why?
|
| Triazoles | 1 | 2015 | 911 | 0.090 |
Why?
|
| Abruptio Placentae | 1 | 2011 | 118 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 4 | 1996 | 4462 | 0.090 |
Why?
|
| Gene Expression | 2 | 2022 | 7799 | 0.090 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 2703 | 0.090 |
Why?
|
| Thrombopoietin | 2 | 2001 | 225 | 0.080 |
Why?
|
| Pulmonary Embolism | 1 | 2021 | 2376 | 0.080 |
Why?
|
| Abnormalities, Multiple | 1 | 1996 | 1416 | 0.080 |
Why?
|
| Neutrophils | 1 | 2021 | 3719 | 0.080 |
Why?
|
| Stillbirth | 1 | 2011 | 346 | 0.080 |
Why?
|
| Female | 15 | 2024 | 380194 | 0.080 |
Why?
|
| Cytokines | 2 | 2019 | 7322 | 0.080 |
Why?
|
| Nitric Oxide Synthase | 2 | 2001 | 916 | 0.080 |
Why?
|
| Apoptosis | 2 | 2001 | 9727 | 0.070 |
Why?
|
| Chromosome Mapping | 1 | 1996 | 4740 | 0.070 |
Why?
|
| Cell-Derived Microparticles | 1 | 2008 | 168 | 0.070 |
Why?
|
| Polysaccharides | 1 | 2013 | 1053 | 0.070 |
Why?
|
| Intracellular Membranes | 1 | 2007 | 390 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 2699 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2022 | 18029 | 0.070 |
Why?
|
| Abortion, Spontaneous | 1 | 2011 | 544 | 0.070 |
Why?
|
| X Chromosome | 3 | 1993 | 814 | 0.070 |
Why?
|
| Organelles | 1 | 2007 | 264 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 16689 | 0.060 |
Why?
|
| Cell Proliferation | 2 | 2018 | 10481 | 0.060 |
Why?
|
| Endothelial Cells | 2 | 2021 | 3479 | 0.060 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 11031 | 0.060 |
Why?
|
| Lung | 1 | 2022 | 9856 | 0.060 |
Why?
|
| Indicators and Reagents | 1 | 2024 | 462 | 0.060 |
Why?
|
| Cells, Cultured | 3 | 2021 | 19229 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2001 | 534 | 0.050 |
Why?
|
| Blood Coagulation Tests | 1 | 2024 | 263 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 2016 | 3507 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2019 | 11483 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 8428 | 0.050 |
Why?
|
| Nitric Oxide Donors | 1 | 2001 | 121 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2001 | 689 | 0.050 |
Why?
|
| Embryo, Mammalian | 1 | 2007 | 1701 | 0.050 |
Why?
|
| False Positive Reactions | 1 | 2024 | 981 | 0.050 |
Why?
|
| Oxypurinol | 1 | 2000 | 8 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2018 | 9734 | 0.050 |
Why?
|
| Cyclic GMP | 1 | 2001 | 409 | 0.050 |
Why?
|
| Nitroso Compounds | 1 | 2000 | 72 | 0.050 |
Why?
|
| Blood Cell Count | 1 | 2021 | 403 | 0.040 |
Why?
|
| Catalase | 1 | 2000 | 222 | 0.040 |
Why?
|
| Multiple Myeloma | 1 | 2018 | 5181 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2007 | 1678 | 0.040 |
Why?
|
| Indomethacin | 1 | 2000 | 332 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2001 | 964 | 0.040 |
Why?
|
| Carcinoma | 1 | 2011 | 2375 | 0.040 |
Why?
|
| Thrombocytopenia | 1 | 2007 | 1179 | 0.040 |
Why?
|
| Genes | 2 | 1993 | 1893 | 0.040 |
Why?
|
| Superoxides | 1 | 2000 | 387 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2019 | 23338 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2000 | 643 | 0.040 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2000 | 295 | 0.040 |
Why?
|
| beta 2-Glycoprotein I | 1 | 2018 | 28 | 0.040 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 2018 | 62 | 0.040 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2000 | 452 | 0.040 |
Why?
|
| Caspase 3 | 1 | 2000 | 758 | 0.040 |
Why?
|
| beta Carotene | 1 | 2019 | 527 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2023 | 77449 | 0.040 |
Why?
|
| Glutathione | 1 | 2000 | 589 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2000 | 597 | 0.040 |
Why?
|
| Fibrinogen | 1 | 2020 | 894 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2021 | 1588 | 0.040 |
Why?
|
| Caspases | 1 | 2000 | 928 | 0.040 |
Why?
|
| Disease Progression | 3 | 2021 | 13284 | 0.040 |
Why?
|
| Cell Line | 2 | 2001 | 15997 | 0.040 |
Why?
|
| Hemostasis | 1 | 1999 | 458 | 0.040 |
Why?
|
| Monoclonal Gammopathy of Undetermined Significance | 1 | 2018 | 177 | 0.030 |
Why?
|
| Antibodies | 1 | 2023 | 2460 | 0.030 |
Why?
|
| DNA, Complementary | 2 | 1996 | 2050 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2000 | 1285 | 0.030 |
Why?
|
| Risk Factors | 2 | 2016 | 72290 | 0.030 |
Why?
|
| Cause of Death | 1 | 2005 | 3584 | 0.030 |
Why?
|
| Prognosis | 3 | 2018 | 29063 | 0.030 |
Why?
|
| United States | 1 | 2022 | 69872 | 0.030 |
Why?
|
| Models, Biological | 1 | 2011 | 9583 | 0.030 |
Why?
|
| Mice, Inbred C3H | 1 | 1996 | 964 | 0.030 |
Why?
|
| Models, Animal | 1 | 2021 | 2171 | 0.030 |
Why?
|
| Propensity Score | 1 | 2021 | 1781 | 0.030 |
Why?
|
| Retina | 3 | 1993 | 2616 | 0.030 |
Why?
|
| Thromboembolism | 1 | 2020 | 986 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 15165 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2000 | 1434 | 0.030 |
Why?
|
| Introns | 1 | 1996 | 991 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 1655 | 0.030 |
Why?
|
| Kinetics | 1 | 2000 | 6473 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2000 | 6314 | 0.030 |
Why?
|
| Vitreous Body | 1 | 1993 | 389 | 0.030 |
Why?
|
| Male | 10 | 2021 | 350118 | 0.030 |
Why?
|
| Base Sequence | 4 | 1996 | 12797 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1996 | 2839 | 0.020 |
Why?
|
| DNA Primers | 1 | 1996 | 2892 | 0.020 |
Why?
|
| Immediate-Early Proteins | 1 | 1993 | 453 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 1996 | 4320 | 0.020 |
Why?
|
| Exons | 1 | 1996 | 2437 | 0.020 |
Why?
|
| Molecular Sequence Data | 4 | 1996 | 18111 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2000 | 2948 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2012 | 546 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2000 | 4161 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2001 | 14557 | 0.020 |
Why?
|
| Platelet Membrane Glycoprotein IIb | 1 | 2008 | 53 | 0.020 |
Why?
|
| Child Behavior Disorders | 1 | 1993 | 807 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 1993 | 1401 | 0.020 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2008 | 141 | 0.020 |
Why?
|
| Alleles | 1 | 2019 | 6933 | 0.020 |
Why?
|
| Critical Illness | 1 | 2021 | 2670 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2021 | 3679 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2000 | 4554 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2007 | 319 | 0.020 |
Why?
|
| Contractile Proteins | 1 | 2008 | 246 | 0.020 |
Why?
|
| Retinal Diseases | 1 | 1993 | 683 | 0.020 |
Why?
|
| Phosphatidylserines | 1 | 2008 | 193 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2019 | 3297 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1996 | 6171 | 0.020 |
Why?
|
| P-Selectin | 1 | 2008 | 600 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2012 | 3689 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 1993 | 1676 | 0.020 |
Why?
|
| Cell Communication | 1 | 2012 | 1621 | 0.020 |
Why?
|
| Genotype | 1 | 2019 | 12951 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 2007 | 634 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 2382 | 0.010 |
Why?
|
| Atherosclerosis | 1 | 2019 | 3445 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2008 | 1152 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 9959 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 1993 | 1622 | 0.010 |
Why?
|
| Middle Aged | 3 | 2021 | 213383 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 9438 | 0.010 |
Why?
|
| Actins | 1 | 2008 | 2121 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2018 | 21746 | 0.010 |
Why?
|
| Bleeding Time | 1 | 1999 | 89 | 0.010 |
Why?
|
| Thromboxane B2 | 1 | 1999 | 152 | 0.010 |
Why?
|
| Selectins | 1 | 1999 | 102 | 0.010 |
Why?
|
| Mutation | 2 | 1993 | 29786 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2005 | 63114 | 0.010 |
Why?
|
| Aged | 2 | 2021 | 163280 | 0.010 |
Why?
|
| Pedigree | 2 | 1993 | 4644 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2019 | 53288 | 0.010 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 1993 | 37 | 0.010 |
Why?
|
| Sequence Homology | 1 | 1993 | 203 | 0.010 |
Why?
|
| Dosage Compensation, Genetic | 1 | 1993 | 211 | 0.010 |
Why?
|
| Growth Substances | 1 | 1993 | 784 | 0.010 |
Why?
|
| Mucins | 1 | 1993 | 564 | 0.010 |
Why?
|
| von Willebrand Factor | 1 | 1993 | 669 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1993 | 2256 | 0.010 |
Why?
|
| Atrophy | 1 | 1993 | 1583 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1993 | 2008 | 0.000 |
Why?
|
| Genetic Linkage | 1 | 1993 | 2421 | 0.000 |
Why?
|
| Eye Diseases | 1 | 1993 | 669 | 0.000 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 1993 | 770 | 0.000 |
Why?
|
| Heterozygote | 1 | 1993 | 2804 | 0.000 |
Why?
|
| Syndrome | 1 | 1993 | 3251 | 0.000 |
Why?
|
| Brain | 1 | 1993 | 26385 | 0.000 |
Why?
|
| Swine | 1 | 1993 | 5917 | 0.000 |
Why?
|
| Membrane Proteins | 1 | 1999 | 7880 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 1999 | 21827 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1993 | 13815 | 0.000 |
Why?
|
| Proteins | 1 | 1993 | 6103 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1993 | 25625 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1993 | 41006 | 0.000 |
Why?
|
| Child | 1 | 1993 | 77709 | 0.000 |
Why?
|
| Adolescent | 1 | 1993 | 85781 | 0.000 |
Why?
|